腾博会官网·[中国]-诚信为本,专业服务!

LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

RESIGNATION OF EXECUTIVE DIRECTOR AND CHIEF EXECUTIVE OFFICER AND APPOINTMENT OF CHIEF EXECUTIVE OFFICER

CHANGE OF ADDRESS OF HONG KONG BRANCH SHARE REGISTRAR AND TRANSFER OFFICE

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2022

VOLUNTARY ANNOUNCEMENT - APPLICATION FOR MARKETING OF CATEGORY 1 INNOVATIVE DRUG “TQ-B3101 CAPSULE”

VOLUNTARY ANNOUNCEMENT - ACQUISITION OF F-STAR THERAPEUTICS, INC.

ADJUSTMENT TO CONVERSION PRICE OF EURO750,000,000 ZERO COUPON CONVERTIBLE BONDS DUE 2025

VOLUNTARY ANNOUNCEMENT CATEGORY 1 INNOVATIVE DRUG “TQC2938” INJECTION APPROVED FOR CLINICAL TRIAL